Stay updated on Efprezimod Alfa as Immunomodulator in COVID-19 Clinical Trial

Sign up to get notified when there's something new on the Efprezimod Alfa as Immunomodulator in COVID-19 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efprezimod Alfa as Immunomodulator in COVID-19 Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page no longer shows a 403 Forbidden message and instead displays the ClinicalTrials.gov site shell with a blank study-details area. The footer revision label changes from v3.7.1 to v3.7.2.
    Difference
    0.6%
    Check dated 2026-10-17T22:41:07.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The page continues to show a 403 Forbidden error, and the displayed site revision changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T22:29:34.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error for the study record, replacing the previous content with a standard error screen and navigation. This makes the study details inaccessible on the page.
    Difference
    19%
    Check dated 2026-09-19T22:18:20.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    The page now displays a new revision label v3.6.6, replacing v3.6.5. This indicates a page update with no apparent changes to the study data or sections.
    Difference
    0.1%
    Check dated 2026-08-29T20:03:57.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    The revision label at the bottom of the page updated from v3.6.4 to v3.6.5, indicating a minor release of the page's software or content. This update does not change the study details or visible information on the page.
    Difference
    0.0%
    Check dated 2026-08-08T23:31:51.000Z thumbnail image
  7. Check
    88 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.3 to v3.6.4, indicating a minor maintenance release.
    Difference
    0.0%
    Check dated 2026-07-25T13:06:17.000Z thumbnail image

Stay in the know with updates to Efprezimod Alfa as Immunomodulator in COVID-19 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efprezimod Alfa as Immunomodulator in COVID-19 Clinical Trial page.